FORTIS Charts, Analysis and Tips

home > pharma-and-healthcare > hospitals-and-medical-services > fortis

Technical Analysis

Technical Strength: 2 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 42.8. According to RSI analysis, fortis is weak. 3.0 FORTIS RSI Chart
MACD (?) MACD: -0.657 and Signal Line: -0.507. According to MACD analysis, a bearish crossover just happend and it's a negative signal. 2.0 FORTIS MACD Chart
Simple Moving Average (?) According to simple moving average analysis, fortis is in a strong downtrend. Major resistance levels are 148.99, 150.183, 177.41. 0.0 FORTIS Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, fortis is in a strong downtrend. Major resistance levels are 149.6084, 152.7417, 168.6869. 0.0 FORTIS Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.25. 5.0 FORTIS Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above 38.2% level. Support is at 142.1097. Resistance levels are 147.225 and 152.3403. 3.0 FORTIS Fibonacci Retracement Chart
Average True Range (?) ATR: 5.02 NA FORTIS Average True Range Chart
Average Directional Index (?) ADX is 15.4 which means FORTIS is in a trading range and there is no trend. NA FORTIS Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
October 19, 2017
Open Price 148.9
High Price 148.9
Low Price 145.05
Close Price 146.0
Absolute Change -1.45
Percentage Change -0.983%
Weekly Change -2.63%
Monthly Change -4.92%
Yearly Change -18.1%
52-week high 228.95
52-week low 125.55
Corporate Actions
ExDate Purpose
September 16, 2016 ANNUAL GENERAL MEETING
September 18, 2014 Annual General Meeting
August 18, 2009 Rhts Eq 2:5 & 2 Wrnt:2 Eq
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.764
Confidence in Beta6.91%
Market Capital Rs. 6759.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. -2.5
TTM Price-to-Earnings (P/E) Ratio -58.4
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 19 October 2017: Deliverable Quantity:3.86e+05 NA FORTIS Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 19 October 2017: Daily Volatility:0.3802 NA FORTIS Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 19 October 2017: PCR_OI:0.524 PCR:0.603 NA FORTIS PCR Chart
Option Pain (?) 19 October 2017: Max Pain:150.0 NA FORTIS Option Pain Chart
Premium (?) 19 October 2017 Premium: 0.0 Futures OI:39808800.0 NA FORTIS Premium Chart
Option_MAX_OI (?) 19 October 2017: Price:146.0 Put with maximum OI:140.0 Call with maximum OI:160.0 NA FORTIS Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
October 26, 2017 146.0 39808800.0 555.0 628.0 146.0
November 30, 2017 146.75 1692900.0 66.0 83.0 146.0

Announcements

September 28, 2017 FortShareholders meetingtis Healthcare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 26, 2017. Further, the company has informed the Exchange regarding voting results.
September 27, 2017 FortShareholders meetingtis Healthcare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 26, 2017.
See all Announcements

Board Meetings

Date Meeting Date Purpose
August 01, 2017 August 04, 2017 The Results/Others Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held August 04, 2017, To, inter-alia, consider and approve the Un-Audited Financial Results for the quarter ended June 30, 2017. The Company has now informed the Exchange that the Board shall also be considering an enabling fund raising option including but not limited to qualified institutions placement (QIP), Foreign Currency Convertible Bond (FCCB), convertible securities or any other method and if approved to recommend the same to the shareholders for their approval at the ensuing annual general meeting of the Company. (Purpose Revised).
July 28, 2017 August 04, 2017 To, Results inter-alia, consider and approve the Un-Audited Financial Results for the quarter ended June 30, 2017.
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 140.6 Rs. 142.8 Rs. 144.4 Rs. 146.7 Rs. 148.2 Rs. 150.5 Rs. 152.1